--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

EXHIBIT 10

 
SHARE EXCHANGE AGREEMENT

SHARE EXCHANGE AGREEMENT (this "Agreement") is made this 15th day of October
2007, by and between Universal Fog, Inc., a Delaware corporation (“UFOG”);
Thomas Bontems, the Chief Executive Officer of UFOG (“Bontems”); Sun Xin, a
citizen and resident of the People’s Republic of China and majority shareholder
of UFOG (the “Majority Shareholder”) and 100% owner of the share capital of
China Health Industries Holdings Limited; China Health Industries Holdings
Limited, a corporation organized under the laws of the Hong Kong SAR of the
People’s Republic of China (“China Health”) and the owner of 100% of the share
capital of Harbin Humankind Biology Technology Co. Limited; and Harbin Humankind
Biology Technology Co. Limited, a corporation organized under the laws of the
People’s Republic of China (“Harbin Humankind”)(China Health and Harbin
Humankind being hereinafter referred to as the “Harbin Subsidiaries”); all of
whom execute and deliver this Agreement, based on the following:

Recitals

WHEREAS, UFOG wishes to acquire one hundred percent (100%) of all of the issued
and outstanding share capital of China Health from the Majority Shareholder in
an exchange for sixty million (60,000,000) shares of common stock of UFOG in a
transaction intended to qualify as a tax-free exchange pursuant to sections 351
and 368(a)(1)(B) of the Internal Revenue Code of 1986, as amended.

WHEREAS, in furtherance thereof, the respective Boards of Directors of UFOG and
the Harbin Subsidiaries, have approved the exchange, upon the terms and subject
to the conditions set forth in this Agreement, pursuant to which one hundred
percent (100%) of the share capital of China Health (the "China Health Share
Capital”) issued and outstanding prior to the exchange, will be exchanged by the
Majority Shareholder in the aggregate for 60,000,000 shares of common stock,
$.0001 par value, of UFOG (the "UFOG Common Stock").

WHEREAS, neither party is seeking tax counsel or legal or accounting opinions on
whether the transaction qualifies for tax free treatment.

Agreement

Based on the stated premises, which are incorporated herein by reference, and
for and in consideration of the mutual covenants and agreements hereinafter set
forth, the mutual benefits to the parties to be derived herefrom, and other good
and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, it is hereby agreed as follows:

ARTICLE I
EXCHANGE OF SHARE CAPITAL FOR STOCK

1.01 Exchange of Share Capital for Stock. On the terms and subject to the
conditions set forth in this Agreement, on the Closing Date (as defined in
Section 1.05 hereof), the Majority Shareholder  shall assign, transfer, and
deliver to UFOG, free and clear of all liens, pledges, encumbrances, charges,
restrictions, or claims of any kind, nature, or description, the China Health
Share Capital, and UFOG agrees to acquire such share capital on such date by
issuing and delivering in exchange therefore to the Majority Shareholder the
UFOG Common Stock. All shares of UFOG Common Stock to be issued and delivered
pursuant to this Agreement shall be appropriately adjusted to take into account
any stock split, stock dividend, reverse stock split, recapitalization, or
similar change in the UFOG Common Stock which may occur between the date of the
execution of this Agreement and the Closing Date.

1.02 Delivery of China Health Share Capital by the Majority Shareholder. The
transfer of the China Health Share Capital by the Majority Shareholder shall be
effected by the delivery to UFOG at the Closing (as set forth in Section 1.05
hereof) of an endorsement of the share capital in the name of UFOG followed by
registration of the same in the name of UFOG with the appropriate government
ministry of China.

1.03 Operation as Wholly-Owned Subsidiary. After giving effect to the
transaction contemplated hereby, UFOG will own one hundred percent (100%) of all
of the share capital of China Health and China Health will be a wholly-owned
subsidiary of UFOG operating under the name “China Health Industries Holdings
Limited”, a corporation organized and existing under the laws of the Hong Kong
SAR of the People’s Republic of China.  Harbin Humankind will become a
wholly-owned indirect subsidiary of UFOG operating under the name “Harbin
Humankind Biology Technology Co. Limited,” a corporation organized and existing
under the laws of the People’s Republic of China.

1.04 Further Assurances. At the Closing and from time to time thereafter, the
Majority Shareholder shall execute such additional instruments and take such
other action as UFOG may reasonably request, without undue cost to the Majority
Shareholder in order to more effectively sell, transfer, and assign clear title
and ownership in the China Health Share Capital to UFOG.

1.05 Closing and Parties. The Closing contemplated hereby shall be held at a
mutually agreed upon time and place on or before October 31, 2007, or on another
date to be agreed to in writing by the parties (the "Closing Date”). The
Agreement may be closed at any time following approval by a majority of Board of
Directors of UFOG and by a majority of the Board of Directors of the Harbin
Subsidiaries and the approval of the Majority Shareholder. The Closing may be
accomplished by wire, express mail, overnight courier, conference telephone call
or as otherwise agreed to by the respective parties or their duly authorized
representatives.

- 1 -

--------------------------------------------------------------------------------

 
 
1.06 Closing Events.

(a)  
UFOG Deliveries. Subject to fulfillment or waiver of the conditions set forth in
Article IV, UFOG shall deliver to the Majority Shareholder at Closing all the
following:

(i)  
A certificate of good standing from the Department of the Secretary of the State
of  Delaware, issued as of a date within ten days prior to the Closing Date,
certifying that UFOG is in good standing as a corporation in the State of
Delaware;

(ii)  
Incumbency and specimen signature certificates dated the Closing Date with
respect to the officers of UFOG executing this Agreement and any other document
delivered pursuant hereto on behalf of UFOG;

(iii)  
Copies of the resolutions/consents of UFOG’s board of directors and shareholder
minutes or consents authorizing the execution and performance of this Agreement
and the contemplated transactions, certified by the secretary or an assistant
secretary of UFOG as of the Closing Date;

(iv)  
The certificate contemplated by Section 4.01, duly executed by the chief
executive officer of UFOG;

(v)  
The certificate contemplated by Section 4.02, dated the Closing Date, signed by
the chief executive officer of UFOG;

(vi)  
Certificates for 60,000,000 shares of UFOG Common Stock issued in the name of
the Majority Shareholder;  and

(vii)  
In addition to the above deliveries, UFOG shall take all steps and actions as
the Majority Shareholder may reasonably request or as may otherwise be
reasonably necessary to consummate the transactions contemplated hereby.

(b)  
China Health Deliveries. Subject to fulfillment or waiver of the conditions set
forth in Article V, the Harbin Subsidiaries and/or the Majority Shareholder
shall deliver to UFOG at Closing all the following:

(i)  
Incumbency and specimen signature certificates dated the Closing Date with
respect to the officers executing this Agreement and any other document
delivered pursuant;

(ii)  
Copies of resolutions/consents of the board of directors of China Health
authorizing the execution and performance of this Agreement and the contemplated
transactions, certified by the secretary or an assistant secretary of China
Health as of the Closing Date;

(iii)  
The certificate contemplated by Section 5.01, executed by the Majority
Shareholder; and

(iv)  
The certificate contemplated by Section 5.02, dated the Closing Date, signed by
the chief executive officer of Harbin Humankind.

(v)  
In addition to the above deliveries, China Health and/or the Majority
Shareholder shall take all steps and actions as UFOG may reasonably request or
as may otherwise be reasonably necessary to consummate the transactions
contemplated hereby.

1.07    Director and Officer Resignations.
At Closing, the current Board of Directors of UFOG shall appoint such director
nominees as may be designated by the Majority Shareholder to fill vacancies on
the Board of Directors of UFOG, and, thereafter, the current directors of UFOG
shall resign. In addition, at closing all officers of UFOG shall tender their
resignations to the Board of Directors, and new officers of UFOG shall be
appointed by the newly appointed Board of Directors of UFOG.  All such director
and officer resignations shall be in compliance with the Securities Exchange Act
of 1934, as amended, and pursuant to a previously filed Information Statement on
Schedule 14F-1 prepared and filed by UFOG.

ARTICLE II
REPRESENTATIONS, COVENANTS AND WARRANTIES OF UFOG, ETC.

As an inducement to, and to obtain the reliance of the Majority Shareholder and
the Harbin Subsidiaries, UFOG and Bontems, jointly and severally, represent,
promise and warrant as follows:

2.01           Organization.
UFOG is, and will be at Closing, a corporation duly organized, validly existing,
and in good standing under the laws of the State of Delaware and has the
corporate power and is and will be duly authorized, qualified, franchised, and
licensed under all applicable laws, regulations, ordinances, and orders of
public authorities to own all of its properties and assets and to carry on its
business in all material respects as it is now being conducted, and there are no
other jurisdictions in which it is not so qualified in which the character and
location of the assets owned by it or the nature of the material business
transacted by it requires qualification, except where failure to do so would not
have a material adverse effect on its business, operations, properties, assets
or condition. The execution and delivery of this Agreement does not, and the
consummation of the transactions contemplated by this Agreement in accordance
with the terms hereof will not, violate any provision of UFOG’s Articles of
Incorporation or Bylaws, or other agreement to which it is a party or by which
it is bound.

2.02           Approval of Agreement; Enforceability.
UFOG has full power, authority, and legal right and has taken, or will take, all
action required by law, its Articles of Incorporation, Bylaws, and otherwise to
execute and deliver this Agreement and to consummate the transactions herein
contemplated. The board of directors of UFOG has authorized and approved the
execution, delivery, and performance of this Agreement. This Agreement, when
delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of UFOG and Bontems enforceable in accordance with its terms,
except as such enforceability may be limited by general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies. The UFOG shareholders will not have dissenter’s rights with
respect to any of the transactions contemplated herein.

- 2 -

--------------------------------------------------------------------------------

 
 
2.03           Capitalization.
The authorized capitalization of UFOG consists of 300,000,000 shares of common
stock, $0.0001 par value, of which 44,694,634 shares were issued and outstanding
as of September 10, 2007. There are 10,000,000 authorized shares of preferred
stock, $.0001 par value, and 4,000,000 shares of convertible preferred stock are
issued and outstanding. There are, and at the Closing, there will be no
outstanding subscriptions, options, warrants, convertible securities, calls,
rights, commitments or agreements calling for or requiring issuance or transfer,
sale or other disposition of any shares of capital stock of the Company or
calling for or requiring the issuance of any securities or rights convertible
into or exchangeable (including on a contingent basis) for shares of capital
stock.  All of the outstanding shares of UFOG are duly authorized, validly
issued, fully paid and non-assessable and not issued in violation of the
preemptive or other right of any person.  There are no dividends due, to be paid
or in arrears with respect to any of the capital stock of Company.

2.04           Financial Statements.
(i)  UFOG has previously delivered to China Health an audited balance sheet of
UFOG as of December 31, 2006, and the related statements of operations,
stockholders' equity (deficit), and cash flows for the fiscal year ended
December 31, 2006, including the notes thereto, and an unaudited balance sheet
of UFOG as of June 30, 2007, and the related unaudited statements of operations,
stockholders’ equity (deficit), and cash flows for the fiscal quarter ended June
30, 2007 (collectively the “Financial Statements”) and the accompanying
auditor’s report to the effect that such audited financial statements contain
all adjustments (all of which are normal recurring adjustments) necessary to
present fairly the results of operations and financial position for the periods
and as of the dates indicated.

(ii)  The Financial Statements of UFOG delivered pursuant to Section 2.04(i)
have been prepared in accordance with generally accepted accounting principles
consistently applied throughout the periods involved as explained in the notes
to such financial statements. The UFOG Financial Statements present fairly, in
all material respects, as of the closing date, the financial position of UFOG.
UFOG will not have, as of the Closing Date, any liabilities, obligations or
claims against it (absolute or contingent), and all assets reflected on such
financial statements present fairly the assets of UFOG in accordance with
generally accepted accounting principles.

(iii)  UFOG has filed or will file as the Closing Date its tax returns required
to be filed for its two most recent fiscal years and will pay all taxes due
thereon. All such returns and reports are accurate and correct in all material
respects. UFOG has no liabilities with respect to the payment of any federal,
state, county, local, or other taxes (including any deficiencies, interest, or
penalties) accrued for or applicable to the period ended on the closing date and
all such dates and years and periods prior thereto and for which UFOG may at
said date have been liable in its own right or as transferee of the assets of,
or as successor to, any other corporation or entity, except for taxes accrued
but not yet due and payable, and to the best knowledge of UFOG, no deficiency
assessment or proposed adjustment of any such tax return is pending, proposed or
contemplated. None of such income tax returns has been examined or is currently
being examined by the Internal Revenue Service and no deficiency assessment or
proposed adjustment of any such return is pending, proposed or contemplated.
UFOG has not made any election pursuant to the provisions of any applicable tax
laws (other than elections that relate solely to methods of accounting,
depreciation, or amortization) that would have a material adverse affect on
UFOG, its financial condition, its business as presently conducted or proposed
to be conducted, or any of its respective properties or material assets. There
are no outstanding agreements or waivers extending the statutory period of
limitation applicable to any tax return of UFOG.

2.05           Information.
The information concerning UFOG set forth in this Agreement is complete and
accurate in all respects and does not contain any untrue statement of a fact or
omit to state a fact required to make the statements made, in light of the
circumstances under which they were made, not misleading. UFOG shall cause the
information delivered by it pursuant hereto to the Majority Shareholder to be
updated after the date hereof up to and including the Closing Date.

2.06           Absence of Certain Changes or Events.
Except as set forth in this Agreement, since the date of the most recent UFOG
balance sheet described in Section 2.04 and included in the information referred
to in Section 2.05:

(a)  There has not been: (i) any adverse change in the business, operations,
properties, level of inventory, assets, or condition of UFOG; or (ii) any
damage, destruction, or loss to UFOG (whether or not covered by insurance)
adversely affecting the business, operations, properties, assets, or conditions
of UFOG;

(b)  UFOG has not: (i) amended its Articles of Incorporation or Bylaws; (ii)
declared or made, or agreed to declare or make, any payment of dividends or
distributions of any assets of any kind whatsoever to stockholders or purchased
or redeemed, or agreed to purchase or redeem, any of its capital stock; (iii)
waived any rights of value which in the aggregate are extraordinary or material
considering the business of UFOG; (iv) made any material change in its method of
management, operation, or accounting; (v) entered into any other material
transactions; (vi) made any accrual or arrangement for or payment of bonuses or
special compensation of any kind or any severance or termination pay to any
present or former officer or employee; (vii) increased the rate of compensation
payable or to become payable by it to any of its officers or directors or any of
its employees whose monthly compensation exceeds $1,000; or (viii) made any
increase in any profit-sharing, bonus, deferred compensation, insurance,
pension, retirement, or other employee benefit plan, payment, or arrangement
made to, for, or with its officers, directors, or employees;

(c)  UFOG has not: (i) granted or agreed to grant any options, warrants, or
other rights for its stocks, bonds, or other corporate securities calling for
the issuance thereof; (ii) borrowed or agreed to borrow any funds or incurred,
or become subject to, any material obligation or liability (absolute or
contingent) except liabilities incurred in the ordinary course of business;
(iii) paid any material obligation or liability (absolute or contingent) other
than current liabilities reflected in or shown on the most recent UFOG balance
sheet and current liabilities incurred since that date in the ordinary course of
business; (iv) sold or transferred, or agreed to sell or transfer, any of its
material assets, properties, or rights (except assets, properties, or rights not
used or useful in its business which, in the aggregate have a value of less than
$5,000 or canceled, or agreed to cancel, any debts or claims (except debts and
claims which in the aggregate are of a value of less than $5,000); (v) made or
permitted any amendment or termination of any contract, agreement, or license to
which it is a party if such amendment or termination is material, considering
the business of UFOG; or (vi) issued, delivered, or agreed to issue or deliver
any stock, bonds, or other corporate securities including debentures (whether
authorized and unissued or held as treasury stock); and

(d)  UFOG has not become subject to any law, order, investigation, inquiry,
grievance or regulation which materially and adversely affects, or in the future
would be reasonably expected to adversely affect, the business, operations,
properties, assets, or condition of UFOG.

- 3 -

--------------------------------------------------------------------------------

 
 
2.07           Litigation and Proceedings.
There are no material actions, suits, claims, or administrative or other
proceedings pending, asserted or unasserted, threatened by or against UFOG or
adversely affecting UFOG or its properties, at law or in equity, before any
court or other governmental agency or instrumentality, domestic or foreign, or
before any arbitrator of any kind.  UFOG is not in default of any judgment,
order, writ, injunction, decree, award, rule, or regulation of any court,
arbitrator, or governmental agency or instrumentality.

2.08           Compliance With Laws; Government Authorization.
(a) UFOG and its officers and directors have complied with all federal, state,
county and local laws, ordinances, regulations, inspections, orders, judgments,
injunctions, awards or decrees applicable to it or its business, including
federal and state securities laws. UFOG and its officers, directors and
beneficial owners are not under investigation by any federal, state, county or
local authorities, including the Commission. UFOG and its officers, directors
and beneficial owners have not received notification from any federal, state,
county, or local authorities, including the Commission,  that it or any of its
officers or directors will be the subject of a legal action or that the
Commission’s Division of Enforcement will be recommending to the Commission that
a Federal District Court or Commission administrative action or any other action
be filed or taken against UFOG and its officers, directors and beneficial
owners.

(b)  UFOG has all licenses, franchises, permits, and other governmental
authorizations that are legally required to enable it to conduct its business in
all material respects as conducted on the date of this Agreement. No
authorization, approval, consent, or order of, or registration, declaration, or
filing with, any court or other governmental body is required in connection with
the execution and delivery by UFOG of this Agreement and the consummation by
UFOG of the transactions contemplated hereby.
 
2.09           Securities and Exchange Commission Compliance of UFOG. UFOG has a
class of securities registered pursuant to Section 12 of the Securities Exchange
Act of 1934, as amended (“Exchange Act”) and has complied in all respects with
Rule 14(a) and 14(c) of the Exchange Act, and with Sections 13 and 15(d) of the
Exchange Act, and UFOG, its management and beneficial owners have complied in
all respects with Sections 13(d) and 16(a) of the Exchange Act.

2.10           Contract Defaults.
UFOG is not in default under the terms of any outstanding contract, agreement,
lease, or other commitment, and there is no event of default or other event
which, with notice or lapse of time or both, would constitute a default in any
respect under any such contract, agreement, lease, or other commitment.

2.11           No Conflict With Other Instruments.
The execution of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in the breach of any term or
provision of, or constitute an event of default under, any material indenture,
mortgage, deed of trust, or other material contract, agreement, or instrument to
which UFOG is a party or to which any of its properties or operations are
subject.

2.12           Subsidiary.
UFOG beneficially owns all of the outstanding capital stock of Universal Fog,
Inc., an Arizona corporation, and it does not own either beneficially or of
record any equity interest in any other company. UFOG does not have a
predecessor as that term is defined under generally accepted accounting
principles or Regulation S-X promulgated by the Securities and Exchange
Commission.

2.13           UFOG Documents.
UFOG has delivered to the Majority Shareholder copies of the following
documents, which are collectively referred to as the "UFOG Documents" and which
consist of the following dated as of the date of execution of this Agreement,
all certified by a duly authorized officer of UFOG as complete, true, and
accurate:

(a)  A copy of the Articles of Incorporation and Bylaws of UFOG in effect as of
the date of this Agreement;

(b)  A copy of resolutions adopted by the board of directors of UFOG approving
this Agreement and the transactions herein contemplated;

(c)  A document setting forth a description of any material adverse change in
the business, operations, property, inventory, assets, or condition of UFOG
since the most recent UFOG balance sheet required to be provided pursuant to
Section 2.04 hereof, updated to the Closing Date;

2.14           Quotation on the OTC Bulletin Board. UFOG’s Common Stock is
quoted in good standing on the OTC Bulletin Board under the symbol “UFOG” and
UFOG will retain such quotation and standing on the OTC Bulletin Board until the
Closing of the transactions contemplated herein, without a penalty such as
receipt of an “E” or otherwise being penalized by NASD or the OTCBB.

2.15           Delivery of Shareholder List. Upon execution of this agreement,
UFOG shall deliver a certified shareholder list from its transfer agent setting
forth the name of each UFOG shareholder, the number of shares held by each,
dated as of a date within fifteen days of closing and whether such shares held
are restricted securities. In connection therewith, UFOG represents that none of
its shareholders are nominees for any other person.

2.16  
  Liabilities, Indebtedness, etc.

As of the Closing Date, UFOG shall not have any liabilities or indebtedness as
such terms are defined by Generally Accepted Accounting Principles.
 

 
- 4 -

--------------------------------------------------------------------------------

 
 
 
ARTICLE III
REPRESENTATIONS, COVENANTS, WARRANTIES OF THE MAJORITY SHAREHOLDER AND THE
HARBIN SUBSIDIARIES
 
As an inducement to, and to obtain the reliance of UFOG, the Majority
Shareholder and the Harbin Subsidiaries, jointly and severally, represent and
warrant as follows:

3.01           Organization.
China Health is, and will be on the Closing Date, a corporation duly organized
and validly existing under the laws of the Hong Kong SAR of the People’s
Republic of China, and has the corporate power and is and will be duly
authorized, qualified, franchised, and licensed under all applicable laws,
regulations, ordinances, and orders of public authorities to own all of its
properties and assets and to carry on its business in all material respects as
it is now being conducted, and there are no other jurisdictions in which it is
not so qualified in which the character and location of the assets owned by it
or the nature of the material business transacted by it requires qualification,
except where failure to do so would not have a material adverse effect on its
business, operations, properties, assets or condition of China Health. The
execution and delivery of this Agreement does not, and the consummation of the
transactions contemplated by this Agreement in accordance with the terms hereof
will not, violate any provision of China Health’s constituent documents, or
other material agreement to which it is a party or by which it is bound, nor
will they violate any laws, rules or policies of the government of the Hong Kong
SAR of the People’s Republic of China.

3.02           Approval of Agreement; Enforceability.
China Health has full power, authority, and legal right and has taken, or will
take, all action required by law, its constituent documents, or otherwise to
execute and deliver this Agreement and to consummate the transactions herein
contemplated. The board of directors of China Health has authorized and approved
the execution, delivery, and performance of this Agreement and the transactions
contemplated hereby, subject to the approval of the Majority Shareholder, which
has been obtained, and compliance with any laws, rules or policies of the
government of the Hong Kong SAR of the People’s Republic of China. This
Agreement, when delivered in accordance with the terms hereof, will constitute
the valid and binding obligation of the Majority Shareholder and the Harbin
Subsidiaries enforceable in accordance with its terms, except as such
enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally, the enforcement of creditors’ rights and
remedies.

3.03           Capitalization.
The issued and outstanding share capital of China Health consists of 1,280 USD
as of July 31, 2007. Such share capital is validly issued, fully paid, and
nonassessable.

3.04           Financial Statements.
(a)  Harbin Humankind has previously delivered to UFOG a copy of an audited
balance sheet of Harbin Humankind as of June 30, 2007 and the related audited
statements of operations, cash flows, and share capital for the years ended June
30, 2007 and 2006, including the notes thereto to the effect that such financial
statements contain all adjustments (all of which are normal recurring
adjustments) necessary to present fairly the results of operations and financial
position for the periods and as of the dates indicated.

China Health has previously delivered to UFOG a copy of an audited balance sheet
of China Health as of July 31, 2007 and the related audited statements of
operations, cash flows, and share capital for the period from July 20, 2007
(Inception) through July 31, 2007, including the notes thereto to the effect
that such financial statements contain all adjustments (all of which are normal
recurring adjustments) necessary to present fairly the results of operations and
financial position for the periods and as of the dates indicated.

(b)  The audited financial statements delivered pursuant to Section 3.04(a) have
been prepared in accordance with generally accepted accounting principles
consistently applied in the United States, throughout the periods involved. The
financial statements of Harbin Humankind and China Health, respectively, present
fairly, as of their respective dates, the financial position of Harbin Humankind
and China Health, respectively. Harbin Humankind and China Health, respectively,
did not have, as of the date of any such balance sheets, except as and to the
extent reflected or reserved against therein, any liabilities or obligations
(absolute or contingent) which should be reflected in any financial statements
or the notes thereto prepared in accordance with generally accepted accounting
principles in the United States, and all assets reflected therein present fairly
the assets of Harbin Humankind and China Health, respectively, in accordance
with generally accepted accounting principles in the United States. The
statements of revenue and expenses and cash flows present fairly the financial
position and results of operations of Harbin Humankind and China Health,
respectively, as of their respective dates and for the respective periods
covered thereby.

3.05           Outstanding Warrants and Options.
China Health has no issued warrants or options, calls, or commitments of any
nature relating to the China Health Share Capital, except as previously
disclosed in writing to UFOG.

3.06           Information.
The information concerning the Harbin Subsidiaries set forth in this Agreement
is complete and accurate in all material respects and does not contain any
untrue statement of a material fact or omit to state a material fact required to
make the statements made, in light of the circumstances under which they were
made, not misleading. The Harbin Subsidiaries shall cause the information
required to be delivered by them pursuant to this Agreement to UFOG to be
updated after the date hereof up to and including the Closing Date.

- 5 -

--------------------------------------------------------------------------------

 
 
3.07           Absence of Certain Changes or Events.
Except as set forth in this Agreement, since the date of the most recent Harbin
Humankind balance sheet described in Section 3.04 and included in the
information referred to in Section 3.06:

(a) There has not been: (i) any material adverse change in the business,
operations, properties, level of inventory, assets, or condition of Harbin
Humankind; or (ii) any damage, destruction, or loss to Harbin Humankind
materially and adversely affecting the business, operations, properties, assets,
or conditions of Harbin Humankind;

(b)  Harbin Humankind has not: (i) amended its constituent documents; (ii)
declared or made, or agreed to declare or make, any payment of dividends or
distributions of any assets of any kind whatsoever to holders of share capital
or purchased or redeemed, or agreed to purchase or redeem, any of its share
capital; (iii) waived any rights of value which in the aggregate are
extraordinary and material considering the business of Harbin Humankind; (iv)
made any material change in its method of accounting; (v) entered into any other
material transactions other than those contemplated by this Agreement; (vi) made
any material accrual or material arrangement for or payment of bonuses or
special compensation of any kind or any severance or termination pay to any
present or former officer or employee; or (vii) made any material increase in
any profit-sharing, bonus, deferred compensation, insurance, pension,
retirement, or other employee benefit plan, payment, or arrangement made to,
for, or with their officers, directors, or employees;

(c)  Harbin Humankind has not (i) granted or agreed to grant any options,
warrants, or other rights for its share capital, bonds, or other corporate
securities calling for the issuance thereof, except as previously disclosed in
writing to UFOG; (ii) borrowed or agreed to borrow any funds or incurred, or
become subject to, any material obligation or liability (absolute or contingent)
except liabilities incurred in the ordinary course of business; (iii) paid any
material obligation or liability (absolute or contingent) other than current
liabilities reflected in or shown on the most recent Harbin Humankind balance
sheet and current liabilities incurred since that date in the ordinary course of
business; (iv) sold or transferred, or agreed to sell or transfer, any of its
material assets, properties, or rights, or agreed to cancel any material debts
or claims; (v) made or permitted any amendment or termination of any contract,
agreement, or license to which it is a party if such amendment or termination is
material, considering the business of Harbin Humankind; or (vi) issued,
delivered, or agreed to issue or deliver any share capital, bonds, or other
corporate securities including debentures (whether authorized and unissued or
held as treasury stock); and

(d)  To the best knowledge of Harbin Humankind, it has not become subject to any
law or regulation which materially and adversely affects, or in the future would
be reasonably expected to adversely affect, the business, operations,
properties, assets, or condition of Harbin Humankind.

3.08           Litigation and Proceedings.
There are no material actions, suits, or proceedings pending or, to the
knowledge of Harbin Humankind, threatened by or against Harbin Humankind or
adversely affecting Harbin Humankind, at law or in equity, before any court or
other governmental agency or instrumentality, domestic or foreign, or before any
arbitrator of any kind.  Harbin Humankind does not have any knowledge of any
default on its part with respect to any judgment, order, writ, injunction,
decree, award, rule, or regulation of any court, arbitrator, or governmental
agency or instrumentality.

3.09           Material Contract Defaults.
Harbin Humankind is not in default in any material respect under the terms of
any outstanding contract, agreement, lease, or other commitment which is
material to the business, operations, properties, assets, or condition of Harbin
Humankind, and there is no event of default or other event which, with notice or
lapse of time or both, would constitute a default in any material respect under
any such contract, agreement, lease, or other commitment in respect of which
Harbin Humankind has not taken adequate steps to prevent such a default from
occurring.

3.10           No Conflict With Other Instruments.
The execution of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in the breach of any term or
provision of, or constitute an event of default under, any material indenture,
mortgage, deed of trust or other material contract, agreement, or instrument to
which Harbin Humankind is a party or to which any of its properties or
operations are subject.

3.11           Governmental Authorizations.
Harbin Humankind has all licenses, franchises, permits, and other governmental
authorizations that are legally required to enable it to conduct its business in
all material respects as conducted on the date of this Agreement.  No
authorization, approval, consent, or order of, or registration, declaration, or
filing with, any court or other governmental body is required in connection with
the execution and delivery by Harbin Humankind of this Agreement and the
consummation by Harbin Humankind of the transactions contemplated hereby.

- 6 -

--------------------------------------------------------------------------------

 
 
3.12           Compliance With Laws and Regulations.
Harbin Humankind has complied with all applicable statutes and regulations of
any governmental entity or agency thereof having jurisdiction over Harbin
Humankind, except to the extent that noncompliance would not materially and
adversely affect the business, operations, properties, assets, or condition of
Harbin Humankind or except to the extent that noncompliance would not result in
the occurrence of any material liability for Harbin Humankind. The consummation
of this transaction will comply with all applicable laws, rules and policies of
the government of the People’s Republic of China.

3.14           Subsidiaries.
Harbin Humankind does not own beneficially or of record equity securities in any
subsidiary that has not been previously disclosed to UFOG.

3.15           Harbin Humankind Documents.
Harbin Humankind has delivered to UFOG the following documents, which are
collectively referred to as the "Harbin Humankind Documents" and which consist
of the following dated as of the date of execution of this Agreement, all
certified by the Chief Executive Officer of Harbin Humankind as complete, true,
and accurate:

(a)  A copy of all of Harbin Humankind’s constituent documents and all
amendments thereto in effect as of the date of this Agreement;

(b)   Copies of resolutions adopted by the board of directors of Harbin
Humankind approving this Agreement and the transactions herein contemplated;

(c)  A document setting forth a description of any material adverse change in
the business, operations, property, inventory, assets, or condition of Harbin
Humankind since the most recent Harbin Humankind balance sheet required to be
provided pursuant to Section 3.04 hereof, updated to the Closing Date;

ARTICLE IV
CONDITIONS PRECEDENT TO OBLIGATIONS OF THE MAJORITY SHAREHOLDER AND THE HARBIN
SUBSIDIARIES

The obligations of the Majority Shareholder and the Harbin Subsidiaries under
this Agreement are subject to the satisfaction or waiver, at or before the
Closing Date, of the following conditions:

4.01           Accuracy of Representations.
The representations and warranties made by UFOG in this Agreement were true when
made and shall be true at the Closing Date with the same force and effect as if
such representations and warranties were made at and as of the Closing Date, and
UFOG shall have performed or complied with all covenants and conditions required
by this Agreement to be performed or complied with by UFOG prior to or at the
Closing.  The Majority Shareholder shall be furnished with a certificate, signed
by a duly authorized officer of UFOG and dated the Closing Date, to the
foregoing effect.

4.02           Officer's Certificate.
The Majority Shareholder shall have been furnished with a certificate dated the
Closing Date and signed by the duly authorized Chief Executive Officer of UFOG
to the effect that to such officer's best knowledge no litigation, proceeding,
investigation, or inquiry is pending or, to the best knowledge of UFOG
threatened, which might result in an action to enjoin or prevent the
consummation of the transactions contemplated by this Agreement.  Furthermore,
based on a certificate of good standing, and UFOG’s own documents and
information, the certificate shall represent, to the best knowledge of the
officer, that:

(a)  This Agreement has been duly approved by UFOG’s board of directors and has
been duly executed and delivered in the name and on behalf of UFOG by its duly
authorized officer pursuant to, and in compliance with, authority granted by the
board of directors of UFOG pursuant to a majority consent;

(b)  There have been no adverse changes in UFOG up to and including the date of
the certificate;

(c)   All conditions required by this Agreement have been met, satisfied, or
performed by UFOG;

(d)   All authorizations, consents, approvals, registrations, reports, schedules
and/or filings with any governmental body including the Securities and Exchange
Commission, agency, or court have been obtained or will be obtained by UFOG and
all of the documents obtained by UFOG are in full force and effect or, if not
required to have been obtained, will be in full force and effect by such time as
may be required; and

(e)  There is no claim action, suit, proceeding, inquiry, or investigation at
law or in equity by any public board or body pending or threatened against UFOG,
wherein an unfavorable decision, ruling, or finding could have an adverse effect
on the financial condition of UFOG, the operation of UFOG, or the transactions
contemplated herein, or any agreement or instrument by which UFOG is bound or in
any way contests the existence of UFOG.

- 7 -

--------------------------------------------------------------------------------

 
 
4.03          No Litigation.
As of the Closing, there shall not be pending any litigation to which UFOG, the
Majority Shareholder, or the Harbin Subsidiaries is a party and which is
reasonably likely to have a material adverse effect on the business of UFOG or
the contemplated transactions.

4.04           Results of Due Diligence Investigation.
The Majority Shareholder shall be satisfied with the results of his due
diligence investigation of UFOG, in his sole discretion.

4.05           UFOG Shall Have No Liabilities as of Closing.
As of the Closing, UFOG shall have no liabilities as such term is defined by
U.S. generally accepted accounting principles.

4.06.          UFOG’s Outstanding Capital Stock at Closing.
As of the Closing, the total outstanding capital stock of UFOG shall consist of
62,234,732 shares of common stock, after giving effect to the 60,000,000 share
issuance contemplated hereby, and there shall be no options, warrants, employee
compensation or other rights to issue common stock or preferred stock issued or
outstanding.

4.07           UFOG Shall Have Filed and Mailed a Schedule 14F-1.
UFOG shall have filed with the Commission and mailed to its shareholders of
record an Information Statement on Schedule 14F-1, and ten days shall have
passed since the date on which it was mailed to shareholders of record.

4.08           Consummation of the 1:20 Reverse Stock Split.
Prior to the Closing, the 1:20 Reverse Stock Split shall have been consummated
by filing an Information Statement on Schedule 14C which shall have been filed
and mailed to shareholders of record, and twenty (20) days thereafter shall have
elapsed.

4.09           No Material Adverse Change.
There shall not be any change in, or effect on, either of Harbin Humankind’s or
UFOG’s assets, financial condition, operating results, customer and employee
relations, or business prospects or the financial statements previously supplied
by Harbin Humankind or UFOG which is, or may reasonably be expected to be,
materially adverse to the business, operations (as now conducted), assets,
prospects or condition (financial or otherwise), of Harbin Humankind or UFOG or
to the contemplated transactions.

4.10.           UFOG’s Over-The-Counter Bulletin Board Quotation.
As of the Closing, the common stock of UFOG shall be quoted on NASD’s
Over-The-Counter Bulletin Board, and shall be in good standing without an “E” or
any other penalty being imposed by NASD or the OTCBB.

4.11           Good Standing.
The Majority Shareholder shall have received a certificate of good standing from
the appropriate authority, dated as of the date within five days prior to the
Closing Date, certifying that UFOG is in good standing as a corporation in the
State of Delaware.

4.12           Other Items.
The Majority Shareholder shall have received from UFOG such other documents,
legal opinions, certificates, or instruments relating to the transactions
contemplated hereby as the Majority Shareholder may reasonably request.

ARTICLE V
CONDITIONS PRECEDENT TO OBLIGATIONS OF UFOG

The obligations of UFOG under this Agreement are subject to the satisfaction, at
or before the Closing Date, of the following conditions:

5.01           Accuracy of Representations.
The representations and warranties made by the Majority Shareholder and the
Harbin Subsidiaries in this Agreement were true when made and shall be true at
the Closing Date with the same force and affect as if such representations and
warranties were made at and as of the Closing Date (except for changes therein
permitted by this Agreement), and the Majority Shareholder and/or the
Harbin  Subsidiaries shall have performed or complied with all covenants and
conditions required by this Agreement to be performed or complied with by them
prior to or at the Closing. UFOG shall be furnished with a certificate, signed
by the Majority Shareholder and dated the Closing Date, to the foregoing effect.
 
5.02           Officer's Certificate.
UFOG shall have been furnished with a certificate dated the Closing Date and
signed by the duly authorized Chief Executive Officer of Harbin Humankind to the
effect that no litigation, proceeding, investigation, or inquiry is pending or,
to the best knowledge of Harbin Humankind, threatened, which might result in an
action to enjoin or prevent the consummation of the transactions contemplated by
this Agreement. Furthermore, based on Harbin Humankind’s own documents, the
certificate shall represent, to the best knowledge of the officer, that:

(a)  This agreement has been duly approved by Harbin Humankind’s board of
directors and stockholders and has been duly executed and delivered in the name
and on behalf of Harbin Humankind by its duly authorized officer pursuant to,
and in compliance with, authority granted by the board of directors of Harbin
Humankind;

(b)  Except as provided or permitted herein, there have been no material adverse
changes in Harbin Humankind up to and including the date of the certificate;
 
- 8 -

--------------------------------------------------------------------------------

(c)  All material conditions required by this Agreement have been met,
satisfied, or performed by Harbin Humankind and/or the Majority Shareholder;

(d)  All authorizations, consents, approvals, registrations, and/or filings with
any governmental body, agency, or court required in connection with the
execution and delivery of the documents by Harbin Humankind and/or the Majority
Shareholder have been obtained and are in full force and effect or, if not
required to have been obtained will be in full force and effect by such time as
may be required; and

(e)  There is no material action, suit, proceeding, inquiry, or investigation at
law or in equity by any public board or body pending or threatened against
Harbin Humankind, wherein an unfavorable decision, ruling, or finding would have
a material adverse affect on the financial condition of Harbin Humankind, the
operation of Harbin Humankind, for the transactions contemplated herein, or any
material agreement or instrument by which Harbin Humankind is bound or would in
any way contest the existence of Harbin Humankind.

5.03           No Litigation.
As of the Closing, there shall not be pending any litigation to which UFOG, any
of the Majority Shareholder or the Harbin Subsidiaries is a party and which is
reasonably likely to have a material adverse effect on the business of Harbin
Humankind or the contemplated transactions.

5.04           Results of Due Diligence Investigation.
UFOG shall be satisfied with the results of its due diligence investigation of
Harbin Humankind, in its sole discretion.

5.05           No Material Adverse Change.
There shall not be any change in, or effect on, Harbin Humankind’s or UFOG’s
assets, financial condition, operating results, customer and employee relations,
or business prospects or the financial statements previously supplied by Harbin
Humankind or UFOG which is, or may reasonably be expected to be, materially
adverse to the business, operations (as now conducted), assets, prospects or
condition (financial or otherwise), of the Majority Shareholder or the Harbin
Subsidiaries or to the contemplated transactions.

5.06  
  Consummation of the 1:20 Reverse Stock Split.

Prior to the Closing, the 1:20 Reverse Stock Split shall have been consummated
by filing an Information Statement on Schedule 14C which shall have been filed
and mailed to shareholders of record, and twenty (20) days thereafter shall have
elapsed.

5.07           Other Items.
UFOG shall have received from the Majority Shareholder and/or the Harbin
Subsidiaries such other documents, legal opinions, certificates, or instruments
relating to the transactions contemplated hereby as UFOG may reasonably request.

ARTICLE VI
SPECIAL COVENANTS

6.01           Activities of UFOG and Harbin Humankind
(a)  From and after the date of this Agreement until the Closing Date and except
as set forth in the respective documents to be delivered by UFOG and Harbin
Humankind pursuant hereto or as permitted or contemplated by this Agreement,
UFOG and Harbin Humankind will each:

(i)  Carry on its business in substantially the same manner as it has
heretofore;
(ii) Maintain in full force and effect insurance, if any, comparable in amount
and in scope of coverage to that now maintained by it;
(iii) Perform in all material respects all of its obligations under material
contracts, leases, and instruments relating to or affecting its assets,
properties, and business;
(iv) Use its best efforts to maintain and preserve its business organization
intact, to retain its key employees, and to maintain its relationships with its
material suppliers and customers;
(v)  Duly and timely file for all taxable periods ending on or prior to the
Closing Date all tax returns required to be filed by or on behalf of such entity
or for which such entity may be held responsible and shall pay, or cause to pay,
all taxes required to be shown as due and payable on such returns, as well as
all installments of tax due and payable during the period commencing on the date
of this Agreement and ending on the Closing Date; and
(vi)  Fully comply with and perform in all material respects all obligations and
duties imposed on it by all laws and all rules, regulations, and orders imposed
by governmental authorities.
 
(b)  From and after the date of this Agreement and except as provided herein
until the Closing Date, UFOG and Harbin Humankind will each not:

(i)  Make any change in its Articles of Incorporation, Bylaws or constituent
documents;
(ii)  Enter into or amend any material contract, agreement, or other instrument
of any of the types described in such party's documents, except that a party may
enter into or amend any contract, agreement, or other instrument in the ordinary
course of business; and
(iii) Enter into any agreement for the sale of UFOG securities or a merger or
sale of substantially all of the assets of UFOG without the prior written
approval of Harbin Humankind.  The provisions governing such exclusivity are set
forth in that certain Letter of Intent dated August 6, 2007, between Harbin
Humankind and UFOG (the “Letter of Intent”).

6.02           Access to Properties and Records.
Until the Closing Date, Harbin Humankind and UFOG will afford to the other
party's officers and authorized representatives and attorneys full access to the
properties, books, and records of the other party in order that each party may
have full opportunity to make such reasonable investigation as it shall desire
to make of the affairs of Harbin Humankind or UFOG and will furnish the other
party with such additional financial and other information as to the business
and properties of Harbin Humankind or UFOG as each party shall from time to time
reasonably request. Additional provisions governing such business review are set
forth in paragraph 5 of the Letter of Intent.
 
- 9 -

--------------------------------------------------------------------------------

6.03           Indemnification by Harbin Humankind and the Majority Shareholder.
(a)           Harbin Humankind will indemnify and hold harmless UFOG and its
directors and officers, and each person, if any, who controls UFOG within the
meaning of the Securities Act from and against any and all losses, claims,
damages, expenses, liabilities, or other actions to which any of them may become
subject under applicable law (including the Securities Act and the Securities
Exchange Act) and will reimburse them for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any claims or
actions, whether or not resulting in liability, insofar as such losses, claims,
damages, expenses, liabilities, or actions arise out of or are based upon: (i)
any untrue statement or alleged untrue statement of a material fact contained in
any of the representations, covenants and warranties set forth herein; or (ii)
the breach of any covenant or agreement set forth herein. The indemnity set
forth herein shall survive the consummation of the transactions herein for a
period of one year.

(b)           The Majority Shareholder will indemnify and hold harmless UFOG,
its directors and officers, and each person, if any, who controls UFOG within
the meaning of the Securities Act from and against any and all losses, claims,
damages, expenses, liabilities, or other actions to which any of them may become
subject under applicable law (including the Securities Act and the Securities
Exchange Act) and will reimburse them for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any claims or
actions, whether or not resulting in liability, insofar as such losses, claims,
damages, expenses, liabilities, or actions arise out of or are based upon: (i)
any untrue statement or alleged untrue statement of a material fact contained in
any of the representations, covenants and warranties set forth herein; or (ii)
the breach of any covenant or agreement set forth herein. The indemnity set
forth herein shall survive the consummation of the transactions herein for a
period of one year.

6.04  
  Indemnification by UFOG and Bontems.

(a)   UFOG will indemnify and hold harmless Harbin Humankind, the Majority
Shareholder, and Harbin Humankind’s directors and officers, and each person, if
any, who controls Harbin Humankind within the meaning of the Securities Act from
and against any and all losses, claims, damages, expenses, liabilities, or
actions to which any of them may become subject under applicable law (including
the Securities Act and the Securities Exchange Act) and will reimburse them for
any legal or other expenses reasonably incurred by them in connection with
investigating or defending any claims or actions, whether or not resulting in
liability, insofar as such losses, claims, damages, expenses, liabilities, or
actions arise out of or are based upon:  (i) any untrue statement or alleged
untrue statement of a material fact contained in any of the representations,
covenants and warranties set forth herein; or (ii) the breach of any covenant or
agreement set forth herein.  The indemnity set forth herein shall survive the
consummation of the transactions herein for a period of one year.

(b)    Bontems will indemnify and hold harmless Harbin Humankind, the Majority
Shareholder,  and Harbin Humankind’s directors and officers, and each person, if
any, who controls Harbin Humankind within the meaning of the Securities Act from
and against any and all losses, claims, damages, expenses, liabilities, or other
actions to which any of them may become subject under applicable law (including
the Securities Act and the Securities Exchange Act) and will reimburse them for
any legal or other expenses reasonably incurred by them in connection with
investigating or defending any claims or actions, whether or not resulting in
liability, insofar as such losses, claims, damages, expenses, liabilities, or
actions arise out of or are based upon: (i) any untrue statement or alleged
untrue statement of a material fact contained in any of the representations,
covenants and warranties set forth herein; or (ii) the breach of any covenant or
agreement set forth herein.  The indemnity set forth herein shall survive the
consummation of the transactions herein for a period of one year.
 
6.05           The Issuance of UFOG Common Stock.
UFOG and the Majority Shareholder understand and agree that the consummation of
this Agreement, including the issuance of the UFOG Common Stock to the Majority
Shareholder as contemplated hereby, constitutes the offer and sale of securities
under the Securities Act and applicable state statutes. UFOG and the Majority
Shareholder agree that such transactions shall be consummated in reliance on an
exemption from registration pursuant to the Securities Act of 1933, as amended
(the “Act”), provided by Regulation S.  Such exemption is based on the following
representations, warranties and covenants made by the Majority Shareholder.

(a)    Regulation S Representations, Warranties and Covenants.
The Majority Shareholder represents and warrants to, and covenants with, UFOG as
follows:

(1)  
The Majority Shareholder is not a U.S. person and is not acquiring the shares of
common stock of UFOG for the account or for the benefit of any U.S. person and
is not a U.S. person who purchased the shares of common stock in a transaction
that did not require registration under the Act.

(2)  
The Majority Shareholder agrees to resell such common stock only in accordance
with the provisions of Regulation S, pursuant to registration under the Act, or
pursuant to an available exemption from registration.

(3)  
The Majority Shareholder agrees not to engage in hedging transactions with
regard to such securities unless in compliance with the Act.

(4)  
The Majority Shareholder consents to the certificate for the shares of common
stock of UFOG to contain a legend to the effect that transfer is prohibited
except in accordance with the provisions of Regulation S, pursuant to
registration under the Act, or pursuant to an available exemption from
registration, and that hedging transactions involving the shares of common stock
may not be conducted unless in compliance with the Act.

(5)  
The Majority Shareholder acknowledges that UFOG has agreed to refuse to register
any transfer of the shares of common stock not made in accordance with the
provisions of Regulation S, pursuant to registration under the Act, or pursuant
to an available exemption from registration.

(6)  
The Majority Shareholder covenants and represents and warrants in favor of UFOG
that all of the representations and warranties set forth herein shall be true
and correct at the time of Closing as if made on that date.

 
(b)  In connection with the transaction contemplated by this Agreement, UFOG
shall file, with its counsel, such notices, applications, reports, or other
instruments as may be deemed necessary or appropriate in an effort to document
reliance on such exemptions, and the appropriate regulatory authority in the
countries where the Majority Shareholder resides unless an exemption requiring
no filing is available in such jurisdictions, all to the extent and in the
manner as may be deemed by such Parties to be appropriate.

6.06           Securities Filings.
UFOG shall be responsible for the preparation and filing of all Securities Act
and Exchange Act filings that may result from the transactions contemplated in
this Agreement, although counsel for the Majority Shareholder may assist with
the preparation and filing.
 
 
- 10 -

--------------------------------------------------------------------------------

 

6.07           Sales of Securities under Rule 144, If Applicable.
(a)  UFOG will use its best efforts to at all times satisfy the current public
information requirements of Rule 144 promulgated under the Act.

(b)  If any certificate representing any such restricted stock is presented to
UFOG’s transfer agent for registration or transfer in connection with any sales
theretofore made under Rule 144, provided such certificate is duly endorsed for
transfer by the appropriate person(s) or accompanied by a separate stock power
duly executed by the appropriate person(s) in each case with reasonable
assurances that such endorsements are genuine and effective, and is accompanied
by an opinion of counsel satisfactory to UFOG and its counsel that such transfer
has complied with the requirements of Rule 144, as the case may be, UFOG will
promptly instruct its transfer agent to allow such transfer and to issue one or
more new certificates representing such shares to the transferee and, if
appropriate under the provisions of Rule 144, as the case may be, free of any
stop transfer order or restrictive legend.

(c)  Other Representations, Warranties and Covenants.

(1)  
The Majority Shareholder has been furnished with and has carefully read the
periodic reports on Forms 10-KSB, 10-QSB and 8-K filed by UFOG with the
Securities and Exchange Commission during the preceding three years.  With
respect to individual or partnership tax and other economic considerations
involved in this investment, the Majority Shareholder confirms that he is not
relying on UFOG (or any agent or representative of UFOG).  The Majority
Shareholder has carefully considered and has, to the extent such person believes
such discussion necessary, discussed with his own legal, tax, accounting and
financial advisers the suitability of an investment in the common stock for such
particular tax and financial situation.

(2)  
The Majority Shareholder acknowledges that UFOG is a “shell company” with no
operations and no significant assets and that, as a result, the consideration
for the Shares far exceeds the value of the Shares under any recognized criteria
of value.  The Majority Shareholder further acknowledges that he is aware of the
quoted prices for UFOG’s common stock on the OTC Bulletin Board but understands
there is no active trading market for such shares, quotations on the OTCBB
represent inter-dealer prices without retail mark-up, mark-down, or commission,
and may not represent actual transactions, and there is no liquid trading market
for UFOG’s common stock.  As a result, there can be no assurance that the
Majority Shareholder will be able to sell the common stock.

(3)  
The Majority Shareholder has had an opportunity to inspect relevant documents
relating to the organization and business of UFOG.  The Majority Shareholder
acknowledges that all documents, records and books pertaining to this investment
which such Majority Shareholder has requested has been made available for
inspection by such Majority Shareholder and his respective attorney, accountant
or other adviser(s).

(4)  
The Majority Shareholder and/or his respective advisor(s) has/have had a
reasonable opportunity to ask questions of, and receive answers and request
additional relevant information from, the officers of UFOG concerning the
transactions contemplated by this Agreement.

(5)  
The Majority Shareholder confirms that he is not acquiring the common stock as a
result of or subsequent to any advertisement, article, notice or other
communication published in any newspaper, magazine or similar media or broadcast
over television or radio or presented at any seminar.

(6)  
The Majority Shareholder, by reason of such person’s business or financial
experience, has the capacity to protect his own interests in connection with the
transactions contemplated by this Agreement.

(7)  
Except as set forth in this Agreement, the Majority Shareholder represents that
no representations or warranties have been made to him by UFOG, any officer
director, agent, employee, or affiliate of UFOG, and such Majority Shareholder
has not relied on any oral representation by UFOG or by any of its officers,
directors or agents in connection with his decision to acquire the common stock.

(8)  
The Majority Shareholder represents that neither he nor any of his affiliates is
subject to any of the events described in Section 262(b) of Regulation A
promulgated under the Act.

(9)  
The Majority Shareholder has adequate means for providing for his current
financial needs and contingencies, is able to bear the substantial economic
risks of an investment in the UFOG   common stock for an indefinite period of
time, has no need for liquidity in such investment and, at the present time,
could afford a complete loss of such investment.

(10)  
The Majority Shareholder has such knowledge and experience in financial, tax and
business matters so as to enable him to use the information made available to
him in connection with the transaction to evaluate the merits and risks of an
investment in the UFOG common stock and to make an informed investment decision
with respect thereto.

(11)  
The Majority Shareholder understands that the UFOG common stock constitutes
“restricted securities” that have not been registered under the Securities Act
or any applicable state securities law and he is acquiring the same as principal
for his own account for investment purposes and not for distribution. The
Majority Shareholder acknowledges that the common stock has not been registered
under the Act or under any the securities act of any state or country. The
Majority Shareholder understands further that in absence of an effective
registration statement, the common stock can only be sold pursuant to some
exemption from registration.

(12)  
The Majority Shareholder recognizes that investment in the UFOG common stock
involves substantial risks. The Majority Shareholder acknowledges that he has
reviewed the risk factors identified in the periodic reports filed by UFOG with
the Securities and Exchange Commission. The Majority Shareholder further
confirms that he is aware that no federal or state agencies have passed upon
this transaction or made any finding or determination as to the fairness of this
investment.

(13)  
The Majority Shareholder acknowledges that each stock certificate representing
the common stock shall contain a legend substantially in the following form:

 
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE
“SECURITIES ACT”) PURSUANT TO AN EXEMPTION FROM REGISTRATION AFFORDED BY
REGULATION S AND HAVE NOT BEEN  REGISTERED UNDER APPLICABLE STATE SECURITIES
LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED
UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO
AVAILABLE EXEMPTIONS FROM SUCH REGISTRATION, PROVIDED THAT THE PURCHASER
DELIVERS TO THE COMPANY AN OPINION OF COUNSEL (WHICH OPINION AND COUNSEL ARE
REASONABLY SATISFACTORY TO THE COMPANY) CONFIRMING THE AVAILABILITY OF SUCH
EXEMPTION.  THE HOLDER AGREES TO REFRAIN FROM HEDGING TRANSACTIONS PURSUANT TO
THE REQUIREMENTS OF REGULATION S.
 
- 11 -

--------------------------------------------------------------------------------

 

4.06           Securities Filings.
The Majority Shareholder, as the controlling shareholder of UFOG following
Closing, shall cause UFOG to timely prepare and file all Securities Act and
Exchange Act filings that may result from or be required in connection with the
transactions contemplated in this Agreement.

ARTICLE VII
MISCELLANEOUS

7.01           Brokers.
No broker’s or finder’s fee will be paid in connection with the transaction
contemplated by this Agreement, except for the payment of fees to George Raney,
which is the responsibility of Harbin Humankind.

7.02           No Representation Regarding Tax Treatment.
No representation or warranty is being made by any party to any other party
regarding the treatment of this transaction for federal or state income
taxation.  Each party has relied exclusively on its own legal, accounting, and
other tax adviser regarding the treatment of this transaction for federal and
state income taxes and on no representation, warranty, or assurance from any
other party or such other party's legal, accounting, or other adviser.

7.03           Governing Law.
This Agreement shall be governed by, enforced and construed under and in
accordance with the laws of the State of Delaware without giving effect to
principles of conflicts of law thereunder. All controversies, disputes or claims
arising out of or relating to this Agreement shall be resolved by binding
arbitration. The arbitration shall be conducted in accordance with the
Commercial Arbitration Rules of the American Arbitration Association. Each
arbitrator shall possess such experience in, and knowledge of, the subject area
of the controversy or claim so as to qualify as an “expert” with respect to such
subject matter. The prevailing party shall be entitled to receive its reasonable
attorney’s fees and all costs relating to the arbitration. Any award rendered by
arbitration shall be final and binding on the Parties, and judgment thereon may
be entered in any court of competent jurisdiction.

7.04           Notices.
Any notices or other communications required or permitted hereunder shall be
sufficiently given if personally delivered, if sent by facsimile or telecopy
transmission or other electronic communication confirmed by registered or
certified mail, postage prepaid, or if sent by prepaid overnight courier
addressed as follows:

If to Universal Fog, Inc., to:

1808 South 1st Avenue
Phoenix, AZ  85003

If to Harbin Humankind, to:

168 Binbei Street
Songbei District, Harbin City
Heilongjiang Province, People’s Republic of China

or such other addresses as shall be furnished in writing by any party in the
manner for giving notices, hereunder, and any such notice or communication shall
be deemed to have been given as of the date so delivered or sent by facsimile or
telecopy transmission or other electronic communication, or one day after the
date so sent by overnight courier.

7.05           Attorney's Fees.
In the event that any party institutes any action or suit to enforce this
Agreement or to secure relief from any default hereunder or breach hereof, the
breaching party or parties shall reimburse the non-breaching party or parties
for all costs, including reasonable attorneys' fees, incurred in connection
therewith and in enforcing or collecting any judgment rendered therein.

7.06           Document; Knowledge.
Whenever, in any section of this Agreement, reference is made to information set
forth in the documents provided by UFOG or the Majority Shareholder, such
reference is to information specifically set forth in such documents and clearly
marked to identify the section of this Agreement to which the information
relates. Whenever any representation is made to the "knowledge" of any party, it
shall be deemed to be a representation that no officer or director of such
party, after reasonable investigation, has any knowledge of such matters.
 
7.07           Entire Agreement.
This Agreement represents the entire agreement between the Parties relating to
the subject matter hereof.  All previous agreements between the Parties, whether
written or oral, have been merged into this Agreement.  This Agreement alone
fully and completely expresses the agreement of the Parties relating to the
subject matter hereof.  There are no other courses of dealing, understandings,
agreements, representations, or warranties, written or oral, except as set forth
herein.

7.08           Survival, Termination.
The representations, warranties, and covenants of the respective Parties shall
survive the Closing Date and the consummation of the transactions herein
contemplated for a period of one year from the Closing Date, unless otherwise
provided herein.
 
- 12 -

--------------------------------------------------------------------------------

 
 
7.09           Counterparts.
This Agreement may be executed in multiple counterparts, each of which shall be
deemed an original and all of which taken together shall be but a single
instrument. In addition, facsimile or electronic signatures shall have the same
legally binding effect as original signatures.

7.10           Amendment or Waiver.
Every right and remedy provided herein shall be cumulative with every other
right and remedy, whether conferred herein, at law, or in equity, and such
remedies may be enforced concurrently, and no waiver by any party of the
performance of any obligation by the other shall be construed as a waiver of the
same or any other default then, theretofore, or thereafter occurring or
existing.  At any time prior to the Closing Date, this Agreement may be amended
by a writing signed by all Parties hereto, with respect to any of the terms
contained herein, and any term or condition of this Agreement may be waived or
the time for performance thereof may be extended by a writing signed by the
party or parties for whose benefit the provision is intended.

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed
as of the date first above written.

UNIVERSAL FOG, INC.
 
HARBIN HUMANKIND BIOLOGY
TECHNOLOGY CO. LIMITED
                   
/s/ Thomas Bontems
 
/s/ Sun Xin
Thomas Bontems
 
Sun Xin
Chief Executive Officer
 
Chairman and CEO
                                       
THOMAS BONTEMS
 
SUN XIN
         
/s/Thomas Bontems
 
/s/ Sun Xin
(In His Individual Capacity)
 
(In His Individual Capacity)
                                       
CHINA HEALTH INDUSTRIES HOLDINGS LTD.
                       
 /s/ Sun Xin
     
Sun Xin
     
Chairman and CEO
     

 
 

- 13 -

--------------------------------------------------------------------------------